Key link discovered between tissue cell type and different forms of arthritis
Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.
Read moreShowcasing a new approach to arthritis research
A recent workshop at Pembroke College, Oxford, provided a showcase for research within the Arthritis Therapy Acceleration Programme (A-TAP) aimed at speeding up the delivery of new drugs for immune-mediated inflammatory disease (IMIDs).
Read moreKennedy Trust renews commitment to rheumatology research with £20M
The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of £20M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.
Read moreKennedy Institute of Rheumatology
A world-leading medical research centre where discovery research drives the development of transformative therapies for chronic inflammatory and degenerative disease.
240 Staff, students and academic visitors
30 Nationalities
£70M+ in Research Income
Select Publications
-
Angiocrine signals regulate quiescence and therapy resistance in bone metastasis
Singh A. et al, (2019), JCI Insight, 4
-
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Nayar S. et al, (2019), Proc Natl Acad Sci U S A, 116, 13490 - 13497
-
Distinct fibroblast subsets drive inflammation and damage in arthritis.
Croft AP. et al, (2019), Nature
-
The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis.
Mintz MA. et al, (2019), Immunity
Latest news
Bringing patients closer to arthritis research
8 July 2019